These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31586486)

  • 1. Clinical trials of Cry j 1 and Cry j 2 T-cell epitope peptide-expressing rice in patients with Japanese cedar pollinosis.
    Hashimotoi Y; Kawata M; Mino N; Ogino S; Takeda N; Kawashima K; Takagi H; Wakasa Y; Takano M; Tanaka M; Tohda Y; Tanaka T
    Asian Pac J Allergy Immunol; 2022 Dec; 40(4):386-392. PubMed ID: 31586486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological and Symptomatic Effects of Oral Intake of Transgenic Rice Containing 7 Linked Major T-Cell Epitopes from Japanese Cedar Pollen Allergens.
    Endo T; Asaka D; Nakayama T; Saito S; Kodama H; Mitsuyoshi R; Takaishi S; Sugimoto N; Omae S; Takagi H; Wakasa Y; Ozawa K; Takano M; Takaiwa F; Kojima H; Saito S
    Int Arch Allergy Immunol; 2021; 182(2):109-119. PubMed ID: 32854094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oral administration of transgenic rice containing cedar pollen T-cell epitopes potentially improves medication- and allergy-related quality-of-life scores.
    Endo T; Asaka D; Nakayama T; Saito S; Kodama H; Mitsuyoshi R; Sugimoto N; Omae S; Takagi H; Wakasa Y; Ozawa K; Takano M; Takaiwa F; Kojima H; Saito S
    Allergy Asthma Proc; 2021 Jul; 42(4):293-300. PubMed ID: 34187621
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis.
    Wakasa Y; Takagi H; Hirose S; Yang L; Saeki M; Nishimura T; Kaminuma O; Hiroi T; Takaiwa F
    Plant Biotechnol J; 2013 Jan; 11(1):66-76. PubMed ID: 23066780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis.
    Sone T; Morikubo K; Miyahara M; Komiyama N; Shimizu K; Tsunoo H; Kino K
    J Immunol; 1998 Jul; 161(1):448-57. PubMed ID: 9647255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens.
    Takaishi S; Saito S; Endo T; Asaka D; Wakasa Y; Takagi H; Ozawa K; Takaiwa F; Otori N; Kojima H
    Immunology; 2019 Oct; 158(2):94-103. PubMed ID: 31323138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a rice-based peptide vaccine for Japanese cedar and cypress pollen allergies.
    Takaiwa F; Yang L
    Transgenic Res; 2014 Aug; 23(4):573-84. PubMed ID: 24638148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
    Osada T; Tanaka Y; Yamada A; Sasaki E; Utsugi T
    Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactivity between major IgE core epitopes on Cry j 2 allergen of Japanese cedar pollen and relevant sequences on Cha o 2 allergen of Japanese cypress pollen.
    Miyaji K; Okamoto N; Saito A; Yasueda H; Takase Y; Shimakura H; Saito S; Sakaguchi M
    Allergol Int; 2016 Jul; 65(3):286-92. PubMed ID: 26916996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens.
    Hirahara K; Tatsuta T; Takatori T; Ohtsuki M; Kirinaka H; Kawaguchi J; Serizawa N; Taniguchi Y; Saito S; Sakaguchi M; Inouye S; Shiraishi A
    J Allergy Clin Immunol; 2001 Jul; 108(1):94-100. PubMed ID: 11447388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Clin Exp Allergy; 2005 May; 35(5):664-71. PubMed ID: 15898991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine.
    Hiroi T; Takaiwa F
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys.
    Fujimura T; Fujinami K; Ishikawa R; Tateno M; Tahara Y; Okumura Y; Ohta H; Miyazaki H; Taniguchi M
    Int Arch Allergy Immunol; 2015; 168(1):32-43. PubMed ID: 26524293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of conformational and sequential IgE epitopes on the major allergen Cry j 2 of Japanese cedar (Cryptomeria japonica) pollen in humans by using monoclonal antibodies for Cry j 2.
    Miyaji K; Yurimoto T; Saito A; Yasueda H; Takase Y; Shimakura H; Okamoto N; Kiuchi A; Saito S; Sakaguchi M
    J Clin Immunol; 2013 Jul; 33(5):977-83. PubMed ID: 23504147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of rice seed-based oral allergy vaccine for Japanese cedar pollinosis in Japanese monkeys.
    Saito S; Takagi H; Wakasa Y; Ozawa K; Takaiwa F
    Mol Immunol; 2020 Sep; 125():63-69. PubMed ID: 32650161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of sequential immunoglobulin E-binding epitope of Japanese cedar pollen allergen (Cry j 2) in humans, monkeys and mice.
    Tamura Y; Kawaguchi J; Serizawa N; Hirahara K; Shiraishi A; Nigi H; Taniguchi Y; Toda M; Inouye S; Takemori T; Sakaguchi M
    Clin Exp Allergy; 2003 Feb; 33(2):211-7. PubMed ID: 12580914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological parameters associated with the development of allergic rhinitis: a preliminary prospective study.
    Uekusa Y; Inamine A; Yonekura S; Horiguchi S; Fujimura T; Sakurai D; Yamamoto H; Suzuki H; Hanazawa T; Okamoto Y
    Am J Rhinol Allergy; 2012; 26(2):92-6. PubMed ID: 22487284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Allergol Int; 2009 Jun; 58(2):237-45. PubMed ID: 19307778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, on an experimental allergic rhinitis model in B10.S mice.
    Tsunematsu M; Yamaji T; Kozutsumi D; Murakami R; Kimura S; Kino K
    Allergol Int; 2007 Dec; 56(4):465-72. PubMed ID: 17965586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 26-Week oral safety study in macaques for transgenic rice containing major human T-cell epitope peptides from Japanese cedar pollen allergens.
    Domon E; Takagi H; Hirose S; Sugita K; Kasahara S; Ebinuma H; Takaiwa F
    J Agric Food Chem; 2009 Jun; 57(12):5633-8. PubMed ID: 19462978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.